stella
beta
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma — Stella
Recruiting
Back to Adrenocortical Carcinoma (ACC) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland
View full record on ClinicalTrials.gov